Can RXRX's AI-Based Approach Revolutionize the Drug Discovery Process?

Key Takeaways Recursion uses its AI platform, RecursionOS, to simulate drug interactions and speed up discovery. Partnerships with Bayer and Roche validate RXRX's model and provide recurring tech-licensing revenues. RXRX faces growing competition from TechBio peers like RLAY and SDGR with similarly advanced platforms.Recursion Pharmaceuticals (RXRX) is redefining the traditional model of drug discovery by harnessing the power of artificial intelligence (AI) through its proprietary RecursionOS platform, de ...